ATBECHDEDKESFRGBGRITLILUNLSE..PTIE......FI..........................................................*EPregister to ST.36 EBD process v 1.0 kbaumeister@epo.org (15 Jan 2013)0836383A119980422EP96923503.01996062619980129enenen19950002251P19950629US1996000309119960214GB1998042219981719980422199817

A61K 31/ 00 A I

A61K 31/ 20 A I

A61K 31/ 202 A I

A61K 31/ 22 A I

A61K 31/ 223 A I

A61K 31/ 255 A I

A61K 31/ 415 A I

A61K 31/ 4164 A I

A61K 31/ 425 A I

A61K 31/ 428 A I

A61K 31/ 495 A I

A61K 31/ 66 A I

A61K 31/ 662 A I

A61K 31/ 664 A I

A61K 38/ 03 A I

A61K 38/ 55 A I

A61K 45/ 06 A I

A61P 35/ 00 A I

A61P 43/ 00 A I

enCOMBINATIONS OF INHIBITORS OF FARNESYL-PROTEIN TRANSFERASEfrCOMBINAISONS D'INHIBITEURS DE FARNESYL-PROTEINE TRANSFERASEdeKOMBINATIONEN VON INHIBITOREN VON FARNESYL PROTEIN TRANSFERASEMERCK & CO., INC.126 East Lincoln AvenueRahway, New Jersey 07065USBANYU PHARMACEUTICAL CO., LTD.2-3, Nihonbashi Honcho 2-chomeChuo-ku Tokyo 103JPCASKEY, Charles, T.126 East Lincoln AvenueRahway, NJ 07065USNISHIMURA, Susumu2-3, Nihombashi, Honcho 2-chomeChuo-ku, Tokyo 103JPYONEMOTO, Mari2-3, Nihombashi, Honcho 2-chomeChuo-ku, Tokyo 103JPThompson, John Dr., et alMerck & Co., Inc. European Patent Department Terlings Park Eastwick RoadHarlow, Essex CM20 2QRGBATBECHDEDKESFIFRGBGRIEITLILUNLPTSEUS199601102219960626enWO199700127519970116199704